Entry |
|
Name |
RET fusion kinase to RAS-ERK signaling pathway
|
Definition |
RET* -> RAS -> RAF -> MEK -> ERK |
Expanded |
5979v1 -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00014 | Non-small cell lung cancer |
|
Gene |
5979 | RET; ret proto-oncogene |
3265 | HRAS; HRas proto-oncogene, GTPase |
3845 | KRAS; KRAS proto-oncogene, GTPase |
4893 | NRAS; NRAS proto-oncogene, GTPase |
369 | ARAF; A-Raf proto-oncogene, serine/threonine kinase |
673 | BRAF; B-Raf proto-oncogene, serine/threonine kinase |
5894 | RAF1; Raf-1 proto-oncogene, serine/threonine kinase |
5604 | MAP2K1; mitogen-activated protein kinase kinase 1 |
5605 | MAP2K2; mitogen-activated protein kinase kinase 2 |
5594 | MAPK1; mitogen-activated protein kinase 1 |
5595 | MAPK3; mitogen-activated protein kinase 3 |
|
Variant |
|
Reference |
|
Authors |
Tirro E, Martorana F, Romano C, Vitale SR, Motta G, Di Gregorio S, Massimino M, Pennisi MS, Stella S, Puma A, Giani F, Russo M, Manzella L, Vigneri P |
Title |
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice. |
Journal |
|
Reference |
|
Authors |
Ferrara R, Auger N, Auclin E, Besse B |
Title |
Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer. |
Journal |
|
Reference |
|
Authors |
Santoro M, Moccia M, Federico G, Carlomagno F |
Title |
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues. |
Journal |
|
Reference |
|
Authors |
Al-Jundi M, Thakur S, Gubbi S, Klubo-Gwiezdzinska J |
Title |
Novel Targeted Therapies for Metastatic Thyroid Cancer-A Comprehensive Review. |
Journal |
|
LinkDB |
|